Acquiring Company
Medtronic Diabetes
Acquired Company
EOFlow
Description
Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced it has entered into a set of definitive agreements to acquire EOFlow Co. Ltd. (KOSDAQ: 294090), manufacturer of the EOPatch® device — a tubeless, wearable and fully disposable insulin delivery device. The addition of EOFlow, together with Medtronic's Meal Detection TechnologyTM algorithm and next-generation continuous glucose monitor (CGM), is expected to expand the company's ability to address the needs of more individuals with diabetes, no matter where they are in their treatment journey or preference for how they want their insulin delivered.
Quick answer
Medtronic Diabetes is acquiring EOFlow, announced May 25, 2023.
- How much did Medtronic Diabetes pay for EOFlow?
- The deal value was not disclosed.
- What does Medtronic Diabetes do?
- (www.medtronicdiabetes.com)Medtronic Diabetes is on a mission to alleviate the burden of diabetes by empowering individuals to live life on their terms, with the most advanced diabetes technology and always-on support..
Source: Fundz verified event record.
Other recent acquisitions in Medical Device and Biotechnology
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- Sunmed To Acquire Avanos Medical’S Respiratory Health Business (June 8, 2023)
- Solmetex, Llc Acquires Impladent Ltd. (June 5, 2023)
- Shockwave Medical Completes Acquisition Of Neovasc (April 11, 2023)
- Luciole Medical Ag Announces The Acquisition Of Spiegelberg Gmbh & Co. Kg To Create A Leading Global Brain Monitoring Developer And Provider (June 27, 2023)
- Zavation, A Gemspring Capital Portfolio Company, Acquires Corelink (June 26, 2023)
- Lilly To Acquire Sigilon Therapeutics (June 29, 2023)
Who to call at Medtronic Diabetes, and when
When Medtronic Diabetes changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day Medtronic Diabetes raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Medtronic Diabetes, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Medtronic Diabetes. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Medtronic Diabetes makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Frequently asked
Who acquired EOFlow?
EOFlow was acquired by Medtronic Diabetes. The deal was reported on May 25, 2023. Medtronic Diabetes is privately held and operates in Biotechnology.
When did Medtronic Diabetes acquire EOFlow?
Medtronic Diabetes's acquisition of EOFlow was reported on May 25, 2023. Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced it has entered into a set of definitive agreements to acquire EOFlow Co. Ltd. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does EOFlow do?
(www.eoflow.com) EOFlow Co., Ltd. is a South Korean medical device company founded in 2011 and is headquartered in Seongnam, South Korea, with additional offices in San Jose, California. It is privately held, operating in Manufacturing.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.